Don't miss out in 2026 to be part of a transformative event in the European TPD and induced proximity industry. Partner with us to drive innovation, form valuable connections, and make a lasting impact on the future of therapeutic development.
Why Partner With Us?
Exclusive Networking Opportunities
Connect with top industry leaders, researchers, and innovators in the TPD and induced proximity space. Our event offers unparalleled access to potential partners and collaborators
Showcase Your Brand
Gain visibility and enhance your brand's reputation by sponsoring our event. Highlight your commitment to advancing therapeutic development and innovation.
Access to Cutting-Edge Research
Be the first to learn about the latest breakthroughs and advancements in TPD and induced proximity therapeutics. Stay ahead of the curve by engaging with pioneering research and development.
Collaborative Innovation
Partnering with us provides a platform to collaborate on groundbreaking projects, share knowledge, and drive the future of therapeutic development together.
Investment Opportunities
Discover new investment opportunities and engage with venture capitalists and large pharma companies who are actively investing in the TPD space. Secure funding and support for your innovative projects.
Thought Leadership
Position your company as a thought leader in the field by participating in panel discussions, workshops, and presentations. Share your insights and expertise with a captive audience.
Here is why the TPD Space Continues to be So Hot in Europe:
Therapeutic Potential: with the next generation of degraders coming through, new disease targets are being opened
Mechanistic Versatility: by completely removing disease causing proteins, degraders offer therapeutic advantage over many existing inhibitors
Expanded Target Landscape: degraders make it possible to target traditionally challenging interfaces like protein-protein interactions between
Positive Early Results: promising early results in both preclinical and clinical studies for PROTACs have driven increased interest and investment
Innovation & Investment: a huge influx of investment from venture capital and now large pharma pouring in millions to accelerate research and clinical trials
Who Attended in 2025?
Get in Touch:
If you want to strengthen existing relationships and form new bonds with TPD and induced proximity drug developers, contact us to showcase your capabilities through a bespoke partnerships package.
Interested in partnering?
Contact: Jamie Redmond
Partnerships Director
Tel: +44 (0)20 3141 8700
Email: [email protected]